AFT Pharmaceuticals’ shares fall as drug fails FDA threshold

AFT Pharmaceuticals’ shares fall as drug fails FDA threshold
AFT Pharmaceuticals managing director Hartley Atkinson still believes Pascomer shows promise. (Image: AFT Pharmaceuticals)
Riley Kennedy
AFT Pharmaceuticals’ shares have fallen this morning after the company said a drug it is developing to treat facial angiofibromas (FA) had failed to reach the threshold for US Food and Drug Administration (FDA) registration.The company’s shares declined 3.3% to $3.80 in morning trading, after the pharmaceutical company released the findings of its study of its orphan drug Pascomer, which it said found “statistically significant” benefits. However, it did not reach the threshold on the IGA scale – a five-point...

More Markets

Cannabis rule change having impact
Primary Sector

Cannabis rule change having impact

Regulatory changes in NZ and Germany have made NZ products more available worldwide.

Popeyes gives KFC some crispy competition
Retail

Popeyes gives KFC some crispy competition

Tahua Group is going after Restaurant Brands’ golden goose (chicken).

Investment heaven: public assets and private investors
Infrastructure

Investment heaven: public assets and private investors

Central and local government have billions in assets and need cash. Enter private money?